期刊文献+

福莫特罗/布地奈德干粉剂吸入治疗儿童支气管哮喘疗效分析 被引量:4

原文传递
导出
摘要 目的探讨福莫特罗/布地奈德干粉剂吸入治疗儿童支气管哮喘的临床效果。方法选择扶沟县人民医院2008-10-2010-10支气管哮喘患儿60例,随机分为观察组和对照组。对照组给予布地奈德和沙丁胺醇吸入,观察组给予福莫特罗布地奈德干粉吸入治疗,观察两组症状的改善情况。结果观察组治疗后呼气峰流速显著高于对照组,差异有统计学意义(P<0.05);观察组治疗后第一秒用力呼气容积显著高于对照组,差异有统计学意义(P<0.05)。结论福莫特罗/布地奈德干粉剂吸入治疗能够显著提高支气管哮喘患儿肺功能,效果显著,值得借鉴。
作者 常玲
出处 《中国误诊学杂志》 CAS 2012年第7期1565-1565,共1页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献3

二级参考文献19

  • 1赵建琴,邵洁,钟文伟,罗海燕,李云珠,俞善昌,史桂英,石学耕.喘可治注射液治疗儿童支气管哮喘随机、双盲、安慰剂对照的临床和实验研究[J].临床儿科杂志,2005,23(3):161-164. 被引量:13
  • 2沈自尹,胡国让,许得盛,陈伟华,张玲娟.补肾法预防哮喘的变态和非变态反应机理研究[J].中西医结合杂志,1989,9(2):82-84. 被引量:61
  • 3Global Initiative for Asthma.Guide for asthma management and prevention in children[DB/OL],2006.www.qinasth-ma.org. 被引量:1
  • 4Salome CM,Reddel HK,Ware SI,et al.Effect of budesonide on the perception of induced airway narrowing in subjects with asthma[J].Am J Respir Crit Care Med,2002,165(1):15-21. 被引量:1
  • 5Joos L,Carlen Brutsche IE,Laule-Kilian K,et al.Systemic Th1-and Th2-gene singnals in atopy and asthma[J].Swiss Med Wkly,2004,134(11-12):159-164. 被引量:1
  • 6诗图译 洪建国校.儿童哮喘严重度和控制状况的评估.Pediatrics(中文版),2006,1(1):41-46. 被引量:1
  • 7Balanag VM,Yunus F,Yang PC,et al.Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma[J].Pulm Pharmacol Ther,2006,19(2):139-147. 被引量:1
  • 8Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report [J]. Allergy, 2008, 63(1) :5-34. 被引量:1
  • 9Frank PI, Morris JA, Azell ML, et al. Long term prognosis in preschool children with wheeze: longitudinal postal questionnaire study 1993-2004 [J]. BMJ,2008, 336(7658) : 1423-1426. 被引量:1
  • 10Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates [J]. N Engl J Med, 1995,332 (3) : 133-138. 被引量:1

共引文献67

同被引文献43

  • 1崔德健.支气管哮喘治疗的进展[J].中华结核和呼吸杂志,2004,27(7):474-476. 被引量:33
  • 2黄俊,陆凤翔.实用内科诊疗规范[M].南京:江苏科学技术出版社,2002.17-18. 被引量:7
  • 3Corren J. Cytokine inhibition in severe asthma: current knowl- edge and future directions [ J ]. Curr Opin Pulm Med, 2011, 17 ( 1) : 29-33. 被引量:1
  • 4Nakajima T, Nishimura Y, Nishiuma T, et al. Characteristics of patients with chronic cough who developed classic asthma during the course of cough variant asthma:a longitudinal study[ J ]. Res- piration ,2005, 72 ( 6 ) :606 - 611. 被引量:1
  • 5Um S J, Lam S, Coxson H, et al. Budesonide/formoterol enhances the expression of pro surfactant protein-B in lungs of COPD patients [J]. PLoS One, 2013,8(12) :e83881. 被引量:1
  • 6Holden NS, George T, Rider CF, et al. Induction of regulator of G-protein signaling 2 expression by long-acting 132-adrenoceptor ag- onists and glucocorticoids in human airway epithelial cells [ J ]. J Pharmacol Exp Ther, 2014,348 ( 1 ) : 12-24. 被引量:1
  • 7Alyn H. Morice,Stefan Peterson,Ola Beckman,Zuzana Kukova.??Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: A superiority and therapeutic equivalence study(J)Pulmonary Pharmacology & Therapeutics . 2007 (1) 被引量:1
  • 8PetrPohunek,PiotrKuna,CarinJorup,KrisDe Boeck.??Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma(J)Pediatric Allergy and Immunology . 2006 (6) 被引量:1
  • 9Global Initiative for Asthma.The Global Strategy for Asthma management and Prevention. www ginasthma.org . 2011 被引量:1
  • 10Bisgaard Hans,Le Roux Pascal,Bj?mer Ditlef,Dymek Andrzej,Vermeulen Jan H,Hultquist Christer.Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest . 2006 被引量:1

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部